The Center for Translational Cancer Research

Lynn M. Opdenaker, Ph.D.

CTCR HFGCC Core Contact, Post Doctoral Fellow

Christiana Care Hospital
Helen F. Graham Cancer Center
Graham Center West
4701 Ogletown Stanton Road
Suite 4300
Newark, DE 19713

Phone Number: 
(302) 623-4653

Ph.D., University of Delaware, 2009
B.S., Ursinus College, 2002

 

Expertise Areas: FACSAriaII flow cytometer for cell analysis and cell sorting, supporting research applications from clinical to environmental. Contact Dr. Opdenaker for other support services available at the CTCR Helen F. Graham Center here.


Manuscripts:

Zhang T, Fields JZ, Opdenaker L, Otevrel T, Masuda E, Palazzo JP, Isenberg GA, Goldstein SD, Brandt M, Boman BM.  2010. Survivin-induced Aurora-B kinase activation – A mechanism by which APC mutations contribute to colon cancer development. Am J Pathol. 177:2816-26.  
 

Sloofman LG, Verdelis K, Spevak L, Zayzafoon M, Yamauchi M, Opdenaker LM, Farach-Carson MC, Boskey, AL, Kirn-Safran CB.  2010.  Effect of the HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth. Bone. 47:93-101.  
 

Opdenaker LM, Fields J, Boman BM.  2009.  Stem Cells and Cancer: A Paradigm Shift. World Stem Cell Report, Genetics Policy Institute, Ed. B Siegel, Wellington, FL, pp 90–95.  
 

Opdenaker, LM and MC Farach-Carson.  2009.  Rapamycin selectively reduces the association of transcripts containing complex 5’ UTRs with ribosomes in C4-2B prostate cancer cells. J Cell Biochem. 107:473-81.